
Michael B. Pallay
Examiner (ID: 18905)
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 898 |
| Issued Applications | 438 |
| Pending Applications | 106 |
| Abandoned Applications | 377 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17177281
[patent_doc_number] => 11154510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Process for the preparation of drug loaded microparticles
[patent_app_type] => utility
[patent_app_number] => 15/735127
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17159
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735127 | Process for the preparation of drug loaded microparticles | Jun 10, 2015 | Issued |
Array
(
[id] => 11728002
[patent_doc_number] => 20170189445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'XENON ASSOCIATED WITH AN NMDA RECEPTOR ANTAGONIST FOR CONTROLLING TUMOR PROLIFERATION IN THE CENTRAL NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 15/316227
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5157
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316227 | XENON ASSOCIATED WITH AN NMDA RECEPTOR ANTAGONIST FOR CONTROLLING TUMOR PROLIFERATION IN THE CENTRAL NERVOUS SYSTEM | Jun 7, 2015 | Abandoned |
Array
(
[id] => 11224433
[patent_doc_number] => 09452141
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-09-27
[patent_title] => 'Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process'
[patent_app_type] => utility
[patent_app_number] => 14/701597
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4580
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701597
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/701597 | Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process | Apr 30, 2015 | Issued |
Array
(
[id] => 10331819
[patent_doc_number] => 20150216822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'NANOPARTICULATE CINACALCET COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/689546
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25485
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/689546 | NANOPARTICULATE CINACALCET COMPOSITIONS | Apr 16, 2015 | Abandoned |
Array
(
[id] => 14881391
[patent_doc_number] => 10420713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Patch, set of patches, method and use for medical or cosmetic treatment
[patent_app_type] => utility
[patent_app_number] => 15/304284
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6122
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304284 | Patch, set of patches, method and use for medical or cosmetic treatment | Apr 15, 2015 | Issued |
Array
(
[id] => 17768202
[patent_doc_number] => 11400120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Composition comprising collagen and honey
[patent_app_type] => utility
[patent_app_number] => 15/566457
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4645
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566457 | Composition comprising collagen and honey | Apr 14, 2015 | Issued |
Array
(
[id] => 13760905
[patent_doc_number] => 10172781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Pituitous silicone fluid
[patent_app_type] => utility
[patent_app_number] => 15/327335
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14922
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327335 | Pituitous silicone fluid | Apr 7, 2015 | Issued |
Array
(
[id] => 13760905
[patent_doc_number] => 10172781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Pituitous silicone fluid
[patent_app_type] => utility
[patent_app_number] => 15/327335
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14922
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327335 | Pituitous silicone fluid | Apr 7, 2015 | Issued |
Array
(
[id] => 11262178
[patent_doc_number] => 09486459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Porous silicon drug-eluting particles'
[patent_app_type] => utility
[patent_app_number] => 14/680430
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 8736
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680430
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/680430 | Porous silicon drug-eluting particles | Apr 6, 2015 | Issued |
Array
(
[id] => 10316611
[patent_doc_number] => 20150201614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'Formulation'
[patent_app_type] => utility
[patent_app_number] => 14/674202
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7413
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674202
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/674202 | Stable encapsulated formulation of clomazone | Mar 30, 2015 | Issued |
Array
(
[id] => 12098139
[patent_doc_number] => 09855222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Topical sanitizer that includes avenanthramides'
[patent_app_type] => utility
[patent_app_number] => 14/672057
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 7103
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672057
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/672057 | Topical sanitizer that includes avenanthramides | Mar 26, 2015 | Issued |
Array
(
[id] => 12343314
[patent_doc_number] => 09949935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Rivastigmine transdermal compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 14/666117
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12530
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666117
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666117 | Rivastigmine transdermal compositions and methods of using the same | Mar 22, 2015 | Issued |
Array
(
[id] => 11512971
[patent_doc_number] => 20170080044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE'
[patent_app_type] => utility
[patent_app_number] => 15/126362
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6229
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/126362 | Sublingual delivery of glatiramer acetate | Mar 15, 2015 | Issued |
Array
(
[id] => 11491345
[patent_doc_number] => 20170065531
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-03-09
[patent_title] => 'ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM'
[patent_app_type] => utility
[patent_app_number] => 14/644706
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7656
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644706
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/644706 | Alcohol-resistant oral pharmaceutical form | Mar 10, 2015 | Issued |
Array
(
[id] => 11491345
[patent_doc_number] => 20170065531
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-03-09
[patent_title] => 'ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM'
[patent_app_type] => utility
[patent_app_number] => 14/644706
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7656
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644706
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/644706 | Alcohol-resistant oral pharmaceutical form | Mar 10, 2015 | Issued |
Array
(
[id] => 10280042
[patent_doc_number] => 20150165040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Pharmaceutical Compositions of Oxazolidinone Antimicrobial Agents'
[patent_app_type] => utility
[patent_app_number] => 14/630584
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5062
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630584 | Pharmaceutical Compositions of Oxazolidinone Antimicrobial Agents | Feb 23, 2015 | Abandoned |
Array
(
[id] => 12015855
[patent_doc_number] => 09808543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Iron garnet nanoparticles for cancer radiotherapy and chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 14/600738
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 69
[patent_no_of_words] => 16247
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600738
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600738 | Iron garnet nanoparticles for cancer radiotherapy and chemotherapy | Jan 19, 2015 | Issued |
Array
(
[id] => 10316617
[patent_doc_number] => 20150201621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'ALCOHOL-BASED DISINFECTANT'
[patent_app_type] => utility
[patent_app_number] => 14/600527
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3224
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600527
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600527 | Alcohol-based disinfectant | Jan 19, 2015 | Issued |
Array
(
[id] => 10311464
[patent_doc_number] => 20150196466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'Multi-Step Product For Improving The Appearance And Feel Of Human Skin'
[patent_app_type] => utility
[patent_app_number] => 14/596374
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12424
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14596374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/596374 | Multi-Step Product For Improving The Appearance And Feel Of Human Skin | Jan 13, 2015 | |
Array
(
[id] => 11002456
[patent_doc_number] => 20160199405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Method and Topical Composition for the Treatment of Rosacea and Skin Erythema Using Selenium Sulfide'
[patent_app_type] => utility
[patent_app_number] => 14/594777
[patent_app_country] => US
[patent_app_date] => 2015-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1525
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594777
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/594777 | Method and Topical Composition for the Treatment of Rosacea and Skin Erythema Using Selenium Sulfide | Jan 11, 2015 |